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The polyamines spermidine and spermin¢ are essential for cell proliferation, Most growth factors stimulate polyamine synthesis by inducing 
ornithine decarboxylase activity, which catalyzes the formation of putrescine from ornithine, Patrescine can then be utilized either for polyamine 
biosynthesis or may serve as a ~ubstrate for diamine oxidase (DAO), leading to formation of y-aminobutyrie acid (GABA). Growth of tbe oxyntic 
mueosa of the stomach is stimulated by feeding° by trophic hormones such a~ gastrin and by exogenous administration f patreseine. Conversely. 
fasting, as well as omithine decarboxylas¢ inhibition decrease oxyntic mucosal DNA synthesis. We now demonstrate that fasted rats show a high 
degree of [~H]GABA formation from ['~H]putrescine i  the oxyntie mucosa nd that feeding or injections ofgastrin, caerulein or the DAO.inhibitor 
aminoguunidine d crease such [~H]GABA formation and, instead, stimulate formation of ['~H]sl~rmidine, Moreover. gastrin injections reduced 
ox~,ntie mucosal DAO activity, Thus, oxyntic mueosal DAO activity is regulated by tropic factors and may be involved in growth regulation by 
controlling intramucosal putrescine metabolism. 
Polyamin¢ biosynthesis; ?'-Aminobutyric a id biosynthesis; Growth factor; Aminoguanidine; Oxyntic gland mueosa; Diamine oxidase activity 
I. INTRODUCTION 
Numerous growth factors have been shown to stimu- 
late ornithine decarboxylase (ODC) activity [1-4]. ODC 
initiates polyamine biosynthesis by catalyzing the for- 
mation of the diamine putrescine from ornithine. Pu- 
trescine is then further converted to the polyamines 
spermidine and sp=rmine. A critical concentration of
these molecules i necessary for mitosis, and treatment 
of cells with ODC inhibitors results in mitotic arrest hat 
is reversible only upon administration of exogenous 
polyamines [5,6]. 
The growth and function of the gastric mucosa is 
regulated by fasting and feeding. At least part of these 
responses are mediated by the antropyloric hormone 
gastrin, released in response to feeding. Thus, admini- 
stration of gastrin to starved animals timulates DNA 
synthesis in the oxyntie mueosa [7]. The trophie effects 
of gastrin may have clinical correlates in the oxyntic 
mucosal hyperplasia observed in the Zollinger-Ellison 
syndrome [8] and in endocrine cell hyperplasia in hy- 
pochlorhydria [9,10]. 
Cellular putreseine l vels may be regulated both by 
synthesis, mediated by ODC, by acetylation and by con- 
version of putrescine to T-aminobutyric acid (GABA), 
catalyzed by diamine oxidase (DAO) (cf. [11]). As is the 
case with most other growth factors, inhibition of ODC 
blocks the trophie ffects of gastrin on the oxyntic mu- 
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cosa [12]. Moreover, putreseine injections also stimulate 
oxyntic mucosal growth [13]. 
Thus, intramucosai putrescine metabolism appear to 
be important to oxyntic mucosal growth. We therefore 
decided to study the role of DAO in controlling pu- 
trescine turnover. In vivo conversion of injected [~H]pu- 
trescine to [~HIGABA and [~H]spermidine was studied 
under conditions of fasting, feeding and injections of 
trophi¢ hormones and of the DAO inhibitor aminogua- 
nidine. Moreover, direct measurements of oxyntic mu- 
cosal DAO activity in response to gastrin were carried 
out. The results how that oxyntie mucosal DAO activ- 
ity is strongly controlled by trophic factors. 
2. MATERIALS AND METHODS 
2.1. Animals 
Lewis rats of either sex weighing 150-200 gwere fasted for 48 h and 
killed by a blow on the neck, 15 min to 6 h before sacrifice the animah 
were refed with standard rat chow or received an intraperitoneal 
injection of 250/ag/kg pentagastrin (Peptavlon, ICl-Phanna. Ch~hire, 
UK), 10 gg/kg caeralein (Takus. Farmatalia Carlo Erba, Freiberg, 
Germany), 100 mg/kg aminoguanidinc hemisulfate (Eastman Kodak, 
Rochester. NY. USA) or i~otonic NaCI. In polyamlne/GABA synthe- 
sis experiments, the rat~ also receiv,.xl an intraperitoneal injection of 
1 mCi/kg [2.3-~H]pmrescin¢ (30Ci/mmol/ml, NEN) 4 h before sacri- 
lice. 
2.2. Pcdyantine d termination a d pol),amhtt,/GABA synthesis 
The oxynti¢ mueosu was rinsed in cold saline and homogenized at
4°C in 0.2 M HCIO~, The extracted polyamines and GABA were 
dansylated and separated by HPLC as previously described [14]. Frac- 
tions were collected and subjected to liquid scintillation counting [141. 
2.3. Dtamhte o.vidase assay 
DAO activity wa~ determined by measuring fomaation of [~i-l]-zl- 
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Fig, 1, Effects of fasting, rcfeeding, gastrin, caerulein and amiaoguanidine onsy,tthesis of [~H]GABA and ['~H]spermidin¢ from [~H]putrescine in 
rat oxyntie mucosa. Results are expressed as per cent radioactivity (+_. S,D.) of total in putrescine, G,~BA and spermidine fractions eparated by 
HPLC. '"P<0,001, "'P<0.01 and "P<0,025. compared to fasted rats injected with saline. Numb;ers of rats used are indicated in Table !. 
pyrroline from ['~H]putrescine, Ox~,ntic mueosa was homogenized 
(20,% w/v) with a Potter apparatus in ice-cold 0,1 M sodium phosphate 
buffer pH 7.2, whereafter the homogenate was centrifuged at 2,000 × 
g for 20 rain at 40C. 100.ul of the sup¢rnatant was added to 100/.d 
0.1 M phosphate buffer pH 7,2 containing, as substrate, 2 mM pu- 
trescine and 1/aCi [2,3:H]putrescine (30 Ci/mmol/ml. NEN) (the final 
specific reactivity in assay mixture was 5 btCi/~mol). The assay mixture 
was incubat~l for 1 h at 37°C, and the produced d-pyrroline extracted 
in 1 ml toluene. 500 pl of the toluene phase was subjected toliquid 
scintillation counting using Maxiflaor (J,J. Baker Chemicals BN., 
Deventer. Holland) as scintillate. Insome xperiments. 5 mM acetal- 
dehyde was present inthe assay naixture toprevent loss of A-pyrroline 
by aldehyde hydrogenase ctivity [15]. Assay blanks were prepared 
by incubating samples inthe presence of0.1 mM aminoguanidine [15]. 
All determinations were made in triplicate. 
....4. Proteitl detertttit,ation 
Tissue solubilized in 500/el 0.5 M NaOH was assayed for protein 
by the Lowry method [16]. 
2.5, Statistics 
Significance of the results was determined by the Mann-Whitney 
U-test, 
3. RESULTS 
Starved rats were refed or injected with pentagastrin, 
eaerulein, aminoguanidine or saline. After 2 h (4 h be- 
fore sacrifice) they were injected with [aH]putrescine. 
The amount of 3H label was determined in the pu. 
trescine, GABA and spermidine pools of the oxyntic 
gland area. The total "~H label of these three pools was 
not significantly affected by refeeding, pentagastrin or 
caerulein, compared to saline° whereas aminoguanidine 
increased the total 3H label (Table I). The distribution 
of 3H label in putrescine, GABA and spermidine frac- 
tions (expressed as percent of total radioactivity) was 
greatly affected by the treatments. Thus, in the oxyntic 
mucosa of 48 h starved rats, 45% 3H label was detected 
in the GABA fraction and about 20% in the spermidine 
fraction. No or only very little label was found in the 
spermin¢ fraction. This pattern changed significantly in 
refed rats (Fig. 1). Thus, 3H label in the GABA fraction 
was now reducted to about 10% (P<0.001) and over 
60% was detected in the spermidine fraction (P<0,001), 
As refeeding of starved rats is a potent stimulus for 
release of endogenous gastrin, we tested whether injec- 
tions of pentagastrin to starved rats would mimic the 
effects of feeding. Such injections produced the same 
changes in the distribution of ~H label in the GABA and 
spermidine pools (P<0.002) (Fig. 1). Moreover, injec- 
tion of the gastrin/cholecystokinin analog caerulein pro- 
duced similar changes, although of smaller magnitude 
than those seen after refeeding or gastrin injections. 
Injections of aminoguanidine to starved rats blocked 
the formation of [~H]GABA and increased the forma- 
tion of [~H]spermidine from [3H]putrescine, document- 
ing that DAO activity was responsible for this conver- 
sion (Fig. 1). 
The reduced conversion of putrescine to GABA after 
gastrin injections, indicated that gastrin decreased DAO 
activity. Direct measurements of DAO activity in the 
oxyntie mucosa showed that this was the case. Already 
15 min after gastrin injection the activity of DAO in the 
oxyntic mucosa began to decrease, and after one hour, 
the activity was 64% of the activity in untreated control 
rats (P=0.005) (Fig. 2). Similar results were obtained 
Table I
Total SH label in rat oxyntie mucosa fter different tre~.tments 
Treatment Oxyntic mucosa 
Fasting (control) 104_+ 87 (8) 
Refceding 149 ."- I05 (6) 
Pentagastrin 106__ 58 (4) 
Caerulcin 115 +_ i09 (5) 
Aminoguanidine 244-_ 45'(3) 
Sum of ~H label in putresc[ne, GABA and spermidine pools 4 h after 
injection with ['~H]putrescin¢, Values are means _ S.D. expressed as 
CFM/m8 tissue. Numbers in brackets represent number of rats, 48-h 
starved rats were rcfcd or injected with the different compounds 6 h 
before sacrifice. "P<0.05 as compared to fasted saline-injected rats. 
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Fig. 2. DAO activity in rat oxyntic mucosa 1 h alter intraperitoneal 
injection of gastrin (n=5) or saline (n=5), The DAO assay was also 
performed with surplus of acetaldehyde present in the reaction mix- 
tare to prevent possible aldehyde dehydrogenase activity from affect. 
ing the accumulation ofA-pyrrolin¢. "P<0,01 and *P<0,025, 
lation [19-21] and treatment of Ehrlich ascites tumour- 
bearing mice with immobilized DAO has been found to 
inhibit tumour growth [22]. Moreover, inhibition of 
DAO by aminoguanidine was recently shown to en- 
hance the intestinal adaptive response to resection [23]. 
Our results show that DAO activity is strongly regu- 
lated by trophic factors and indicate that DAO nmy 
play a role in oxyntic mueosal growth regulation by 
controlling putreseine metabolism to GABA and pol- 
yamines. 
An unanswered question is whether GABA, formed 
by the action of DAO, has any effects itself on growth. 
In the central and peripheral nervous system, GABA 
represents a well known neurotransmitter and has been 
shown to have effects on gastrin and somatostatin secre- 
tion from the stomach [24]. 
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when acetaldehyde was present in the reaction mixture 
to prevent possible alterations in aldehyde dehydroge. 
nase activity from affecting the accumulation of d. 
pyrroline. Thus, one hour after gastrin injection DAO 
activity was decreased to 70% of the activity found in 
untreated controls (P=0.016) (Fig. 2). The decrease in 
DAO activity lasted for at least 4 h. 
4. DISCUSSION 
Our results clearly show that a pathway for formation 
of GABA from putrescine exists in the rat oxyntic mu- 
cosa. GABA can be folaned both by decarboxylation f 
glutamate, catalyzed by glutamate decarboxylase and 
from putrescine, catalyzed by DAO and aldehyde dehy- 
drogenase [11]. Previously, the putrescine pathway has 
been shown to exist in several tissues, including the 
liver, small intestine, spleen, kidney and pancreatic slets 
[11,14,17,18]. The fact that injections of aminoguani- 
dine inhibit formation of [~H]GABA from [aH]pu- 
trescine in oxyntic mucosa strongly indicate the involve- 
ment of DAO in this conversion. The DAO catalyzed 
formation of [aH]GABA from [3H]putrescine is signifi- 
cantly decreased by feeding and by injections of gastrin 
or the gastrin/cholecystokinin a alog caerulein. In addi- 
tion, gastrin and aminoguanidine also cause an in- 
creased formation of [3H]spermidine, possibly by in- 
creasing the amount of [3H]putreseine available for 
spermidinc synthase. Direct chemical measurements of 
DAO activity document a significant decrease upon 
gastrin injection. 
DAO has previously been implicated in growth regu- 
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